Assessing patient autonomy in the context of TeamBirth, a quality improvement intervention to improve shared decision‐making during labor and birth von Neergheen, Vanessa L., Chaer, Lynn El, Plough, Avery, Curtis, Elizabeth, Paterson, Victoria J., Short, Trisha, Bright, Amani, Lipsitz, Stuart, Murphy, Aizpea, Miller, Kate, Subramanian, Laura, Radichel, Evelyn, Ervin, John, Castleman, Lindsay, Brown, Erin, Yeboah, Tracy, Simas, Tiffany Moore, Terk, Daniel, Vedam, Saraswathi, Shah, Neel, Weiseth, Amber

Volltext

The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients von El Haddad, Lynn, Ariza-Heredia, Ella, Shah, Dimpy P, Jiang, Ying, Blanchard, Ted, Ghantoji, Shashank S, El Chaer, Firas, El-Haddad, Danielle, Prayag, Amrita, Nesher, Lior, Rezvani, Katy, Shpall, Elizabeth, Chemaly, Roy F

Volltext

1561. Outcomes of Resistant or Refractory CMV Infection in Recipients of Allogeneic Hematopoietic Cell Transplant von Artau, Annette, Aitken, Samuel L, Batista, Marjorie, Chaer, Firas El, Prayag, Amrita, Haddad, Lynn El, Mulanovich, Victor, Ariza-Heredia, Ella, Chemaly, Roy

Volltext

Rhinovirus Infections (RhVI) in 233 Hematopoietic Cell Transplant (HCT) Recipients: A Single Center Experience von Taremi, Mahnaz, Shah, Dimpy, El-Haddad, Danielle, Chaer, Firas El, Haddad, Lynn El, Prayag, Amrita, Rondon, Gabriela, Hosing, Chitra, Ariza-Heredia, Ella, Chemaly, Roy F.

Volltext

The ability of CMV–specific ELISPOT assay to predict outcome of low level CMV reactivation in hematopoietic cell transplant recipients von Shah, Dimpy, Ariza-Heredia, Ella, Chaer, Firas El, Haddad, Lynn El, El-Haddad, Danielle, Prayag, Amrita, Nesher, Lior, Rezvani, Katy, Shpall, Elizabeth, Chemaly, Roy F.

Volltext

Clinical Validation of the Definitions of Resistant and Refractory Cytomegalovirus (CMV) Infection and Disease in Hematopoietic Cell Transplant (HCT) Recipients von Batista, Marjorie V., Artau, Annette, Aitken, Samuel L, Khawaja, Fareed, Chaer, Firas EL, Haddad, Lynn El, Mulanovich, Victor E., Ariza-Heredia, Ella J, Chemaly, Roy F.

Volltext

Outcomes of Resistant or Refractory CMV Infection in Recipients of Allogeneic Hematopoietic Cell Transplant von Artau, Annette, Aitken, Samuel L., El Chaer, Firas, Prayag, Amrita, El Haddad, Lynn, Mulanovich, Victor E., Shah, Dimpy P., Ariza-Heredia, Ella J., Chemaly, Roy F.

Volltext

560 - Outcomes of Resistant or Refractory CMV Infection in Recipients of Allogeneic Hematopoietic Cell Transplant von Artau, Annette, Aitken, Samuel L., El Chaer, Firas, Prayag, Amrita, El Haddad, Lynn, Mulanovich, Victor E., Shah, Dimpy P., Ariza-Heredia, Ella J., Chemaly, Roy F.

Volltext

219 - The Ability of CMV-Specific Elispot Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients von Ariza-Heredia, Ella J., Shah, Dimpy P., El Chaer, Firas, El Haddad, Lynn, El-Haddad, Danielle, Prayag, Amrita, Nesher, Lior, Rezvani, Katy, Shpall, Elizabeth J., Chemaly, Roy F.

Volltext

223 - Drug-Resistant Cytomegalovirus Infections in Hematopoietic Cell Transplant Recipients: A Single Center Retrospective Study von El Chaer, Firas, Prayag, Amrita, El Haddad, Lynn, Mulanovich, Victor E., Shah, Dimpy P., Ariza-Heredia, Ella J., Chemaly, Roy F.

Volltext

The Ability of CMV-Specific Elispot Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients von Ariza-Heredia, Ella J, Shah, Dimpy P, El Chaer, Firas, El Haddad, Lynn, El-Haddad, Danielle, Prayag, Amrita, Nesher, Lior, Rezvani, Katy, Shpall, Elizabeth J, Chemaly, Roy F

Volltext

Drug-Resistant Cytomegalovirus Infections in Hematopoietic Cell Transplant Recipients: A Single Center Retrospective Study von El Chaer, Firas, Prayag, Amrita, El Haddad, Lynn, Mulanovich, Victor E, Shah, Dimpy P, Ariza-Heredia, Ella J, Chemaly, Roy F

Volltext